|Articles|January 1, 2013
- Pharmaceutical Executive-01-01-2013
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - January 2013
Industry Forecast 2013, The Search for Safe Harbors
Advertisement
Articles in this issue
over 12 years ago
Industry Forecast 2013almost 13 years ago
Product Liability Claims and Comment Kalmost 13 years ago
The Force Behind Sales Forcesalmost 13 years ago
The Scoop on Drug Shortagesalmost 13 years ago
Country Report: Singaporealmost 13 years ago
Compliance in the C-Suitealmost 13 years ago
Who Lost Syria?almost 13 years ago
The Long Swim—Upstreamalmost 13 years ago
The Permanent Campaignalmost 13 years ago
Transformation to Characterize 2013Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
